2017 Patient Symposium

Friday, October 27, 2017 - 10:00am to 3:00pm EST

The ILD Collaborative is proud to host:  

THE DR. ANDREW TAGER SYMPOSIUM 
FOR THOSE LIVING WITH IDIOPATHIC PULMONARY FIBROSIS
Friday, October 27, 2017

 

Participation is encouraged by all people impacted by IPF regardless of where their healthcare is provided.

Parking, a light breakfast and lunch will be provided complimentary for attendees.

Please click on the titles of the talks to view the slides. 

AGENDA 

9:00am - 10:00am
Check-in and Light Breakfast 

10:00am - 10:15am
Welcome and Opening Remarks
Dr. Peter LaCamera, SEMC
Dr. Aliaa Barakat, ILD Collaborative
Dr. Rachel Knipe, MGH

10:15am - 10:45am
Drugs for IPF Part 1: Pirfenidone
Dr. Joseph Zibrak, BIDMC
Drugs for IPF Part 2: Nintedanib
Dr. Rob Hallowell, BIDMC
Medications Side Effect Management

10:45am - 11:05am
IPF Co-morbidities and What Can be Done for Them?
Dr. Sydney Montesi, MGH

11:05am - 11:20am
Genomics and IPF
Dr. John Tedrow, SEMC

11:20am - 11:40am
New Directions for IPF Treatments: Update on Clinical Trials
Dr. Barry Shea, RIH

11:40am - 12:00pm
Audience Questions

12:00pm - 1:00pm
Lunch Social (Main Room)

12:20pm - 12:55pm
Discussion Sessions 
Room 1: Lung Transplantation for IPF 
Dr. Todd Astor, MGH
Room 2: Palliative Care and IPF
Dr. Jessica McCannon, MGH

1:00pm - 1:20pm
The Importance of Exercise and Oxygen in IPF
Dr. Fiona Gibbons, MGH
Nancy Davis, RRT, MGH
Abby Folger, PT, DPT, MGH
Jessica Garton, PT, DPT, MGH

1:20pm - 2:05pm
Talking About What Matters: 
A Structured Program to Encourage Serious Illness Conversations
Dr. Daniela Lamas, BWH, Ariadne Labs

2:05pm - 2:25pm
Care of Caregivers; Boston Pulmonary Fibrosis Support Group
Anne LaFleur, LICSW, MGH
Dr. Katharine Black, MGH

2:25pm - 2:55pm
Audience Questions 

2:55pm - 3:00pm
Closing Remarks